PARNF — Parnell Pharmaceuticals Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Parnell Pharmaceuticals Holdings, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.

	2012 June 30th	2013 June 30th	2014 June 30th	2014 December 31st	2015 December 31st
Period Length:	12 M	12 M	12 M	6 M	12 M
Source:	PROSPECTUS	PROSPECTUS	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.078	0.86	20.8	15.8	5.67
Net Total Accounts Receivable
Net Total Receivables	2.93	4.71	3.41	4.83	7.27
Total Inventory
Prepaid Expenses
Total Current Assets	4.41	7.58	26.3	23.9	16.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12.5	12	11.2	11.9	12.7
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	26.7	31.6	47.7	48.2	46.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.09	21.4	10.2	13.6	10.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	20.1	29.2	11	14.3	26
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	6.58	2.39	36.8	33.9	20.3
Total Liabilities & Shareholders' Equity	26.7	31.6	47.7	48.2	46.2
Total Common Shares Outstanding